Finance

Beta
Lists
LALPATHLAB:NSE
Dr. Lal PathLabs Ltd
â‚ą1,541.50
+0.30%
(+4.60) 1D
Jun 8, 2:15:30 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LALPATHLAB...
Open
â‚ą1,510.10
High
â‚ą1,584.40
Low
â‚ą1,500.10
Mkt. cap
257.51B
Avg. vol.
611.84K
Volume
269.48K
Dividend
0.91%
Quarterly dividend
â‚ą3.50
Ex-dividend date
Jun 25, 2026
P/E ratio
51.04
52-wk high
â‚ą1,770.00
52-wk low
â‚ą1,272.60
EPS
â‚ą30.20
Shares outstanding
83.34M
No. of employees
5K
Open
â‚ą1,510.10
High
â‚ą1,584.40
Low
â‚ą1,500.10
Mkt. cap
257.51B
Avg. vol.
611.84K
Volume
269.48K
Dividend
0.91%
Quarterly dividend
â‚ą3.50
Ex-dividend date
Jun 25, 2026
P/E ratio
51.04
52-wk high
â‚ą1,770.00
52-wk low
â‚ą1,272.60
EPS
â‚ą30.20
Shares outstanding
83.34M
No. of employees
5K
News stories
From sources across the web
Profile
Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera. Wikipedia
About Dr. Lal PathLabs Ltd
CEO-
Employees4.98K
Founded1949
Headquarters-
SectorHealth care provider
Websitelalpathlabs.com
Last report
Apr 30, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
â‚ą8.44 / â‚ą7.42
+13.75%beat
Revenue / Est. (INR)
7.03B / 6.75B
+4.04%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.70B
7.31B
6.60B
7.03B
Cost of goods sold
2.61B
2.74B
2.63B
2.64B
Cost of revenue
2.61B
2.74B
2.63B
2.64B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
922.00M
1.06B
958.00M
1.01B
Operating expense
2.51B
2.73B
2.59B
2.96B
Total operating expenses
5.12B
5.47B
5.23B
5.60B
Operating income
1.58B
1.84B
1.37B
1.42B
Other non operating income
281.00M
248.00M
244.00M
240.00M
EBT including unusual items
1.81B
2.04B
1.24B
1.60B
EBT excluding unusual items
1.81B
2.04B
1.54B
1.60B
Income tax expense
471.00M
514.00M
329.00M
279.00M
Effective tax rate
26.01%
25.25%
26.47%
17.43%
Other operating expenses
1.24B
1.26B
1.22B
1.51B
Net income
1.32B
1.51B
905.00M
1.31B
Net profit margin
19.77%
20.61%
13.72%
18.68%
Earnings per share
7.92
9.00
6.73
8.44
Interest and investment income
-
-
-
-
Interest expense
-47.00M
-48.00M
-72.00M
-61.00M
Net interest expenses
-47.00M
-48.00M
-72.00M
-61.00M
Depreciation and amortization charges
346.00M
405.00M
421.00M
446.00M
EBITDA
1.82B
2.21B
1.62B
1.83B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer